The pharmaceutical industry is the leading core industry of Zhongheng Group, and has become a key industry for development in the new industrial structure of the group company. At present, under the guidance of the new development strategy, Wuzhou Pharmaceutical has achieved new development, various economic indicators have reached record highs, and its core industry status has been fully highlighted.
After nearly 50 years of development, Wuzhou Pharmaceutical has become a modern comprehensive high-tech pharmaceutical industry integrating R&D, production and sales. 13 production lines have fully passed GMP certification. Wuzhou Pharmaceutical has very rich resources and outstanding advantages. It has 217 varieties of 11 major categories of dosage forms, 309 approval numbers, 21 exclusive production varieties, 11 protected traditional Chinese medicine varieties, and 4 patented products, which are included in the "Chinese Pharmacopoeia" 92 varieties. The product treatment scope covers bruises, cardiovascular and cerebrovascular diseases, gynecology, respiratory system, urinary system, health care and other fields. "Zhonghua" and "Zhongheng" brands have become two well-known trademarks. The company's leading products, Xueshuantong for injection, Zhonghua Diedai Pills, Fuyanjing Capsules, etc., have broad market prospects and have laid a solid foundation for development of Wuzhou Pharmaceutical's sales.
It is Wuzhou Pharmaceutical’s responsibility to realize the modernization and development of the traditional Chinese medicine industry. Wuzhou Pharmaceutical has a first-class technology research and development center and an excellent scientific research and technical talent team, which can meet the needs of research on various new drugs such as biological products, Chinese patent medicines and chemical drugs, as well as product quality improvement projects, and has mastered the leading domestic traditional Chinese medicine extraction technology and mature and advanced production technology to ensure that product quality reaches leading domestic and international levels. Main products such as Zhonghua Diedai Pills, Fuyanjing Capsules, Kunyue'an Granules, Jianpi Jiangzhi Granules and other products have obtained national invention patents; Xueshuantong for Injection, Zhonghua Diedai Pills, Fuyanjing Capsules, Calculus Tong Tablets, etc. have also obtained national invention patents. Was rated as a high-tech product. The technological advantages created by independent innovation have enhanced Wuzhou Pharmaceutical's core competitiveness.
In the future development, Wuzhou Pharmaceutical will continue to pay attention to people's livelihood, care for health, and make every effort to create good medicines for the general public and benefit human health!
Real estate is the basic industry of Zhongheng Group
The real estate industry is the mature main business of Zhongheng Group and one of the key industries in the industrial structure of the group company. The real estate branch of the group has more than 20 years of development experience and specializes in urban infrastructure construction, comprehensive real estate development, property management and other businesses. It has successfully developed Hengxiang Garden, Shenglong Xiuwan, Wutong Xinyuan, and Hengxiang Phase II. and other series of branded communities; it has also achieved great success in the external expansion of its real estate business, and has successfully developed the "Guilin Hengxiang Garden" high-end residential community and the "Shanghai Blue Castle" villa community in Guilin and Shanghai. With its successive high-quality residential properties, Zhongheng Real Estate has achieved the unification of economic, social and environmental benefits and has considerable influence in the industry.
Now, Zhongheng Group is working hard to promote the further development and expansion of the industry in accordance with the company's new strategy of developing real estate!